Enovix is trading at $2.97, down 5.71%, as technology-sector weakness weighs on shares. - Technology was down 1.50% during the regular session, amid concerns about AI investment returns and recent technology earnings disappointments. - No company-specific announcement explaining Enovix’s decline was found. - Enovix’s $11.0 million preliminary Q3 revenue was reported earlier, on October 12, and is not a new November 2 catalyst. Full Q3 results are scheduled for November 12.